Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pharmacists want role in drug importation

24.11.2004


Many community pharmacists are not opposed to importing drugs to lower patients’ costs as long as those drugs are channeled through U.S. pharmacies to ensure safety and efficacy, according to a study by pharmacists at the University of Illinois at Chicago and the University of Michigan.



The study will appear in the November/December edition of the Journal of the American Pharmacists Association. "Importation of Prescription Medications: The Experiences, Opinions and Intended Behaviors of U.S. Retail Pharmacists" surveyed 401 pharmacists practicing in Illinois, Michigan, Florida and Minnesota.

The pharmacists surveyed expressed concern about safety, liability and the economic ramifications of prescription drug importation. More favorable opinions were expressed if imported drugs are channeled through U.S. pharmacies.


Authors are A. Simon Pickard, assistant professor of pharmacy practice at the UIC College of Pharmacy; Glen Schumock, director of the UIC Center for Pharmacoeconomic Research; David Nau, assistant professor, Center for Medication Use, Policy, and Economics, UM College of Pharmacy; and Patrick McKercher, director of the UM center.

The researchers found that pharmacists are concerned about the safety of imported medications and about job security if no regulatory changes are made.

Pharmacists generally felt that safety concerns regarding importation would be diminished if U.S. pharmacists oversaw the process of importation. "By having the U.S. pharmacy import the drug, the pharmacist may be able to identify potential counterfeits before the products reach the patient," Nau said.

The study also found that community pharmacists are being hit with frequent inquiries from the public about how to obtain medications from outside the United States.

Many pharmacists in Minnesota, Illinois and Michigan responded that they are not happy with the handling of the issue of drug importation by their state governments. Florida pharmacists, however, seemed more satisfied, possibly because Florida has aggressively addressed the problem of the importation of counterfeit drugs.

The pharmacists’ observations can be useful to policy makers, Pickard said. "Because pharmacists are key stakeholders in this debate, our study can inform policy makers about some of the implications of prescription drug reimportation. If such a policy is to be pursued, there will be ramifications for patient care and safety, the domestic work force and the pharmacy profession as a whole."

Results of the study include:

  • Approximately 90 percent of pharmacists surveyed agreed that the Medicare drug benefit would not diminish consumer interest in prescription drug importation, and a similar proportion agreed that interest was not limited to the elderly.
  • 69 percent agreed that their primary concern about importation was the quality or purity of the drugs.
  • 57 percent agreed that drugs purchased through Canada would not pose a greater risk for medication-related problems if U.S. pharmacists oversaw the process and were available to provide patient monitoring and education.
  • Pharmacists strongly favored regulatory actions that may decrease counterfeiting. Thirty-two percent felt consumers should be allowed to legally purchase medications from Canada; 44 percent felt pharmacies should be able to legally procure prescription drugs from Canada. If legally permitted, almost 70 percent said they would consider ordering medications from Canada.
  • Approximately half were concerned about job security as a result of the trend toward importation. This concern was significantly higher among pharmacy owners.

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>